Search


NYSE Market Strategist Eric Criscuolo discusses how the newly appointed Federal Reserve Chair and other market factors might affect the biotech sector
He discusses interest rates, generalist investor participation in the sector, and more.
Feb 2


NYSE Market Strategist Eric Criscuolo discusses biotech's newfound momentum and whether it might attract generalists to take a look at the sector
He discusses the rally biotech has had of late, and that was boosted by Pfizer's deal with the White House. Plus, how interest rates,...
Oct 8, 2025


NYSE Strategist Eric Criscuolo shares his take on the markets and biotech sentiment
He discusses the importance of interest rates to high risk sectors like biotech, and comment on how our sector has not performed lately...
Jul 22, 2025






.png)
